Biomedica Research Group
Biomedica realiza actividades de investigación clínica basadas en las buenas prácticas clínicas (BPC/ICH), cumpliendo con las regulaciones locales (ISP) e internacionales (FDA y EMA). El centro se fundo el año 1999 realizando ensayos en el campo de las neurociencias, ha ido incorporando progresivamente otras áreas médicas. A diciembre de 2022, hemos participado en más de 160 estudios multicéntricos internacionales.Av. Salvador 149, piso 11, Providencia 7500710 - Santiago
Websitehttps://www.biomedica.cl/
Select an option
I am a doctor
I am a sponsor
Specializations
Reumatologia
Cardiologia
Geriatria
Neurologia
Infectologia
Psiquiatria
Our team
Medical staff
Investigador PrincipalPaola Varleta
Sandra Leon
Rebeca Corbalan Buttler
Investigador PrincipalElizabeth Moreno
Investigador PrincipalSergio Gloger Kojchen
María Victoria Chacon
Dante Diez de Medina
Constanza Rodriguez
Maria José Muñoz
Open studies
Lupus
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-1 - BiogenSee more
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - POETYK SLE-2 - Bristol-Myers SquibbSee more
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST) - AMETHYST - BiogenSee more
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus - OPUS-2 - Idorsia Pharmaceuticals Ltd.See more
Depression
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder - NMRA-335140 - Neumora Therapeutics, Inc.See more
Rare diseases
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome - POETYK SjS-1 - Bristol-Myers SquibbSee more
